These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 33117271

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does growth hormone supplementation improve oocyte competence and IVF outcomes in patients with poor embryonic development? A randomized controlled trial.
    Li J, Chen Q, Wang J, Huang G, Ye H.
    BMC Pregnancy Childbirth; 2020 May 20; 20(1):310. PubMed ID: 32434490
    [Abstract] [Full Text] [Related]

  • 4. The effect of administration of intravenous intralipid on pregnancy outcomes in women with implantation failure after IVF/ICSI with non-donor oocytes: A randomised controlled trial.
    Singh N, Davis AA, Kumar S, Kriplani A.
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep 20; 240():45-51. PubMed ID: 31228675
    [Abstract] [Full Text] [Related]

  • 5. Die-off ratio correlates with increased TNF-α:IL-10 ratio and decreased IVF success rates correctable with humira.
    Winger EE, Reed JL, Ashoush S, El-Toukhy T, Taranissi M.
    Am J Reprod Immunol; 2012 Nov 20; 68(5):428-37. PubMed ID: 22845061
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone supplementation may improve the pregnancy rate and endometrial receptivity among women aged more than 40 years undergoing in vitro fertilization.
    Lan KC, Lin PY, Chang YC, Chen YJ, Tsai YR, Ismaeil Mohamed IS, Kang HY.
    Biomed J; 2019 Dec 20; 42(6):411-416. PubMed ID: 31948605
    [Abstract] [Full Text] [Related]

  • 7. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
    Dai X, Wang Y, Yang H, Gao T, Yu C, Cao F, Xia X, Wu J, Zhou X, Chen L.
    Sci Rep; 2020 Nov 12; 10(1):19750. PubMed ID: 33184364
    [Abstract] [Full Text] [Related]

  • 8. Regimen of ovarian stimulation affects oocyte and therefore embryo quality.
    Bosch E, Labarta E, Kolibianakis E, Rosen M, Meldrum D.
    Fertil Steril; 2016 Mar 12; 105(3):560-570. PubMed ID: 26826273
    [Abstract] [Full Text] [Related]

  • 9. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S, Son WY, Gilman A, Younes G, Shavit T, Dahan MH.
    Hum Reprod; 2017 Jan 12; 32(1):119-124. PubMed ID: 27852688
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of donor sperm in addition to oocyte donation after repeated implantation failure in normozoospermic patients does not improve live birth rates.
    Blázquez A, García D, Rodríguez A, Vassena R, Vernaeve V.
    Hum Reprod; 2016 Nov 12; 31(11):2549-2553. PubMed ID: 27609983
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical Outcomes of Frozen-Thawed Embryos Generated From Growth Hormone Stimulation in Expected Poor Responders.
    Zhu J, Wang Y, Chen L, Liu P, Li R, Qiao J.
    Front Endocrinol (Lausanne); 2020 Nov 12; 11():608225. PubMed ID: 33613447
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a recurrent poor-quality embryo morphology phenotype and zygote transfer as a rescue strategy.
    Sermondade N, Delarouzière V, Ravel C, Berthaut I, Verstraete L, Mathieu E, Antoine JM, Mandelbaum J.
    Reprod Biomed Online; 2012 Apr 12; 24(4):403-9. PubMed ID: 22377150
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone supplementation during ovarian stimulation improves oocyte and embryo outcomes in IVF/PGT-A cycles of women who are not poor responders.
    Skillern A, Leonard W, Pike J, Mak W.
    J Assist Reprod Genet; 2021 May 12; 38(5):1055-1060. PubMed ID: 33534048
    [Abstract] [Full Text] [Related]

  • 16. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP.
    Hum Reprod; 2016 Feb 12; 31(2):370-6. PubMed ID: 26724797
    [Abstract] [Full Text] [Related]

  • 17. Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle.
    Barra F, Laganà AS, Scala C, Garzon S, Ghezzi F, Ferrero S.
    Reprod Biomed Online; 2020 Nov 12; 41(5):859-868. PubMed ID: 32873492
    [Abstract] [Full Text] [Related]

  • 18. Use of pentoxifylline during ovarian stimulation to improve oocyte and embryo quality: A retrospective study.
    Vitale SG, Palumbo M, Rapisarda AMC, Carugno J, Conde-López C, Mendoza N, Mendoza-Tesarik R, Tesarik J.
    J Gynecol Obstet Hum Reprod; 2022 Jun 12; 51(6):102398. PubMed ID: 35508290
    [Abstract] [Full Text] [Related]

  • 19. The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.
    Li XL, Wang L, Lv F, Huang XM, Wang LP, Pan Y, Zhang XM.
    Medicine (Baltimore); 2017 Mar 12; 96(12):e6443. PubMed ID: 28328856
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF.
    Yovich JL, Stanger JD.
    Reprod Biomed Online; 2010 Jul 12; 21(1):37-49. PubMed ID: 20457541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.